Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATACAS Trial
2009-015013-46Phase 4Completed
- Sponsor
- Alfred Health
- Start
- Oct 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of aspirin and tranexamic acid in coronary arteriosclerosis (4 arms), sponsored by Alfred Health. Primary endpoints: Primary composite endpoint and All-cause mortality at 30 days. Started Oct 2010; status: completed.
02
Drugs
aspirintranexamic acid
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2009-015013-46.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015013-46.